Generic placeholder image

Current Enzyme Inhibition

Editor-in-Chief

ISSN (Print): 1573-4080
ISSN (Online): 1875-6662

Inhibitors of Nitric Oxide Synthase: What's up and What's Next?

Author(s): Lakshmikirupa Sundaresan, Suvendu Giri and Suvro Chatterjee

Volume 12 , Issue 1 , 2016

Page: [81 - 107] Pages: 27

DOI: 10.2174/1573408012666151126185922

Price: $65

Sekisui-XenoTech-CEI
Abstract

NO is a key signaling molecule that has a wide range of biological functions including vasodilation and neurotransmission, and is implicated in several pathological conditions. Therefore, modulation of NO is a desired step in curbing the NO-associated disease processes. Targetting NOS proteins and inhibiting their activity to reduce NO production is a major approach since the inception of NOS inhibitor research. Although a series of NOS inhibitors have been developed, synthesized and practiced in experimental biology, no NOS inhibitor has been approved as yet a drug for therapeutic uses. The present review elaborates the scope of the clinical uses of NOS inhibitors and the inherent limitations of the process that makes the approach less successful so far in clinic.

Keywords: Nitric Oxide (NO), Nitric Oxide Synthase (NOS), Nitric Oxide Synthase inhibitors, NOS oxidase domain, NOS reductase domain.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy